Home > Annual Financials > KERALA AYURVEDA

KERALA AYURVEDA Financial Statement Analysis
[BOM: 530163]

The Revenues of KERALA AYURVEDA have increased by 15.46% YoY .
The Earnings Per Share (EPS) of KERALA AYURVEDA has decreased by Negative YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

KERALA AYURVEDA Last 5 Annual Financial Results
[BOM: 530163]

ConsolidatedMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹108 Cr₹93 Cr₹80 Cr₹62 Cr₹77 Cr
Expenses ₹101 Cr₹91 Cr₹71 Cr₹61 Cr₹69 Cr
Operating Profit (Excl OI) ₹6.76 Cr₹2.62 Cr₹9.53 Cr₹0.84 Cr₹7.36 Cr
Other Income ₹0.52 Cr₹0.29 Cr₹0.35 Cr₹0.11 Cr₹0.02 Cr
Interest ₹4.66 Cr₹5.19 Cr₹6.67 Cr₹6.41 Cr₹1.70 Cr
Depreciation ₹1.34 Cr₹1.11 Cr₹1.20 Cr₹1.28 Cr₹1.14 Cr
Profit Before Tax ₹1.27 Cr₹-0.56 Cr₹2.81 Cr₹-6.74 Cr₹4.54 Cr
Profit After Tax ₹-0.86 Cr₹-0.43 Cr₹2.39 Cr₹-4.84 Cr₹4.05 Cr
Consolidated Net Profit ₹-1.56 Cr₹-0.53 Cr₹2.36 Cr₹-4.84 Cr₹3.90 Cr
Earnings Per Share (Rs)₹-1.30₹-0.51₹2.24₹-4.59₹3.69
PAT Margin (%)-0.80-0.462.98-7.805.28
ROE(%)-5.44-14.76137.66-183.0393.90
ROCE(%)6.756.1812.62-0.459.27
Total Debt/Equity(x)2.4027.4222.60198.8913.08

Key Financials

Market Cap : ₹ 374.5 Cr
Revenue (TTM) : ₹ 107.3 Cr
Net Profit(TTM) : ₹ -0.2 Cr
EPS (TTM) : ₹ -0.2
P/E (TTM) : -

Industry Peers & Returns1W1M1Y
KERALA AYURVEDA 13.8% 8.7% 23.6%
SUN PHARMACEUTICAL INDUSTRIES -1.4% -7.1% 48%
CIPLA -3.5% -5.2% 18%
DR REDDYS LABORATORIES -3.9% -10.1% 10.1%
ZYDUS LIFESCIENCES -0.3% -7.3% 52.2%
DIVIS LABORATORIES 1.5% -2.1% 63%
MANKIND PHARMA -2.3% -3% 39.6%
TORRENT PHARMACEUTICALS -1.8% -10.2% 51.3%
LUPIN -2.4% -6.4% 73.9%


KERALA AYURVEDA Revenues
[BOM: 530163]

Y-o-Y

15.46 %

5 Yr CAGR

8.87 %

Years Revenues % Change
Mar2024 ₹108 Cr
15.46
Mar2023 ₹93 Cr
16.25
Mar2022 ₹80 Cr
29.45
Mar2021 ₹62 Cr
-19.15
Mar2020 ₹77 Cr -


KERALA AYURVEDA Operating Profit
[BOM: 530163]

Y-o-Y

157.76 %

5 Yr CAGR

-2.11 %

Years Operating Profit % Change
Mar2024 ₹6.76 Cr
157.76
Mar2023 ₹2.62 Cr
-72.49
Mar2022 ₹9.53 Cr
1,034.40
Mar2021 ₹0.84 Cr
-88.58
Mar2020 ₹7.36 Cr -

Operating Margins
Y-o-Y

122.78 %

5 Yr CAGR

-10.09 %

Years Operating Margin% % Change
Mar2024 6.26%
122.78
Mar2023 2.81%
-76.31
Mar2022 11.86%
778.52
Mar2021 1.35%
-85.91
Mar2020 9.58% -

KERALA AYURVEDA Profit After Tax
[BOM: 530163]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2024 ₹-1.56 Cr
Negative
Mar2023 ₹-0.53 Cr
Negative
Mar2022 ₹2.36 Cr
Positive
Mar2021 ₹-4.84 Cr
Negative
Mar2020 ₹3.90 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2024 -0.8 %
Negative
Mar2023 -0.46 %
Negative
Mar2022 2.98 %
Positive
Mar2021 -7.8 %
Negative
Mar2020 5.28 % -

KERALA AYURVEDA Earnings Per Share (EPS)
[BOM: 530163]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2024 ₹-1.30
Negative
Mar2023 ₹-0.51
Negative
Mar2022 ₹2.24
Positive
Mar2021 ₹-4.59
Negative
Mar2020 ₹3.69 -

KERALA AYURVEDA Return on Capital Employed (ROCE)
[BOM: 530163]

Y-o-Y

9.22 %

5 Yr CAGR

-7.62 %

Years ROCE % Change
Mar2024 6.75%
9.22
Mar2023 6.18%
-51.03
Mar2022 12.62%
Positive
Mar2021 -0.45%
Negative
Mar2020 9.27% -

KERALA AYURVEDA Share Price vs Sensex

Current Share Price : ₹312.1
Current MarketCap: ₹ 374.5 Cr
Updated EOD on :Nov 21,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
KERALA AYURVEDA

13.8%

8.7%

23.6%

SENSEX

-1.9%

-5%

17.5%

KERALA AYURVEDA related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about KERALA AYURVEDA Financials


How the annual revenues of KERALA AYURVEDA have changed ?

The Revenues of KERALA AYURVEDA have increased by 15.46% YoY .

How the Earnings per Share (EPS) of KERALA AYURVEDA have changed?

The Earnings Per Share (EPS) of KERALA AYURVEDA has decreased by Negative YoY .